NEW YORK, July 8 - Genedata, of Basel, Switzerland, and Singapore's National Cancer Center said today they have begun a gene-expression analysis collaboration in the area of cancer research.
Under this agreement, the center has licensed Genedata's Expressionist microarray analysis software.
Researchers at the center will use the platform to identify sets of diagnostic marker genes that can be used to classify tissues by type and subtype of cancer; as well as to understand gene function and mechanisms of tumor progression, as well as oncogenic signal transduction pathways, the parties said. Genedata's scientists will work with the center researchers on developing the applications of Expressionist in this area.